IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $505,991 | +10.6% | 11,155 | 0.0% | 0.03% | +8.0% |
Q2 2023 | $457,690 | +14.8% | 11,155 | -0.0% | 0.02% | +13.6% |
Q1 2023 | $398,751 | -5.8% | 11,157 | -0.5% | 0.02% | -12.0% |
Q4 2022 | $423,477 | -15.0% | 11,212 | -0.4% | 0.02% | -24.2% |
Q3 2022 | $498,000 | +19.7% | 11,255 | +0.2% | 0.03% | +26.9% |
Q2 2022 | $416,000 | +0.2% | 11,235 | +0.2% | 0.03% | -3.7% |
Q1 2022 | $415,000 | +21.0% | 11,212 | -0.5% | 0.03% | +22.7% |
Q4 2021 | $343,000 | -8.0% | 11,274 | +1.3% | 0.02% | -15.4% |
Q3 2021 | $373,000 | -16.0% | 11,134 | +0.1% | 0.03% | -25.7% |
Q2 2021 | $444,000 | -11.0% | 11,120 | +0.2% | 0.04% | -68.2% |
Q1 2021 | $499,000 | -20.5% | 11,100 | 0.0% | 0.11% | -29.0% |
Q4 2020 | $628,000 | +18.9% | 11,100 | -0.2% | 0.16% | -3.1% |
Q3 2020 | $528,000 | – | 11,120 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |